This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Biosense Webster (Israel) Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Amir Ben-Dor: Innovator in Cardiac Signal Analysis
Introduction
Amir Ben-Dor is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of cardiac signal analysis, particularly through his innovative patent that addresses the identification of cardiac areas exhibiting progressively slowing activation.
Latest Patents
Amir Ben-Dor holds a patent for a method titled "Identifying and indicating cardiac areas exhibiting progressively slowing activation (PSA)." This method involves receiving a cardiac signal sensed by electrodes located in a patient's heart. The cardiac signal includes various signal components evoked by respective activations. The process includes finding and annotating these signal components, calculating time differences between the annotations and corresponding activations, and identifying one or more cardiac tissue locations that demonstrate progressively slowing activation. An electrophysiological map of the heart is then presented to the user, graphically indicating the identified tissue locations.
Career Highlights
Amir is associated with Biosense Webster (Israel) Ltd., where he applies his expertise in cardiac technology. His work focuses on enhancing the understanding and treatment of cardiac conditions through innovative signal analysis techniques.
Collaborations
Amir collaborates with talented professionals in his field, including Einat Shapira and Gal Hayam. Their combined efforts contribute to advancements in cardiac research and technology.
Conclusion
Amir Ben-Dor's contributions to cardiac signal analysis through his patent demonstrate his commitment to improving patient care in cardiology. His innovative methods pave the way for better diagnostic and treatment options in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile